SKI Market

A+| A| A-|

Indian Indices

Sensex

74,563.92 -1,470.50
( -1.93%)

Global Indices

Nasdaq

46,702.98 -735.30
(-1.55%)

Dow Jones

6,694.68 -102.12
(-1.50%)

Hang Seng

53,838.16 -614.80
(-1.13%)

Nikkei 225

10,300.41 -53.36
(-0.52%)

Forex

USD-INR

91.92 0.02
(0.02%)

EUR-INR

106.58 -0.28
(-0.27%)

GBP-INR

123.39 -0.12
(-0.10%)

JPY-INR

0.58 0.00
(-0.46%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

RRIL Ltd

Industry : Construction

BSE Code

ISIN Demat

Book Value()

531307

INE951M01037

6.5855391

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

154.64

206.19

EPS(TTM)

Face Value()

Div & Yield %

0.11

Back

Board of Remus Pharmaceuticals recommends First Interim Dividend

Nov 10,2025

Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 10 November 2025, has recommended a First Interim Dividend of Rs.0.50 per share (i.e.5%), subject to the approval of the shareholders.

74,563.92 -1,470.50 ( -1.93%)

46,702.98 -735.30 (-1.55%)

6,694.68 -102.12 (-1.50%)

53,838.16 -614.80 (-1.13%)

10,300.41 -53.36 (-0.52%)

91.92 0.02 (0.02%)

106.58 -0.28 (-0.27%)

123.39 -0.12 (-0.10%)

0.58 0.00 (-0.46%)